Reports for FRESENIUS KABI CANADA LTD
Company Name FRESENIUS KABI CANADA LTD |
||
|---|---|---|
Totals |
||
Shortage reports |
341 |
|
| Actual shortage: | 5 (1%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 5 (1%) | |
| Resolved: | 331 (97%) | |
Discontinuation Reports |
2 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 2 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
51 (15%) |
|
Overdue reports |
3 (60%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DEXTROSE 5% INJECTION | 50MG | SOLUTION | Resolved | 2021-12-10 | 2021-12-17 | 150953 |
| DEXTROSE 5% INJECTION | 50MG | SOLUTION | Resolved | 2020-08-20 | 2020-09-01 | 122573 |
| DEXTROSE 5% INJECTION | 50MG | SOLUTION | Resolved | 2020-02-20 | 2020-03-05 | 106782 |
| DIPHENHYDRAMINE HYDROCHLORIDE INJECTION | 50MG | SOLUTION | Resolved | 2022-11-11 | 2023-03-01 | 174351 |
| DIPHENHYDRAMINE HYDROCHLORIDE INJECTION | 50MG | SOLUTION | Resolved | 2022-03-31 | 2022-05-18 | 157671 |
| DIPYRIDAMOLE INJECTION, USP | 5MG | LIQUID | Resolved | 2023-06-02 | 2024-07-02 | 193649 |
| DIPYRIDAMOLE INJECTION, USP | 5MG | LIQUID | Resolved | 2022-10-03 | 2023-04-03 | 170977 |
| DIPYRIDAMOLE INJECTION, USP | 5MG | LIQUID | Resolved | 2021-03-31 | 2021-10-08 | 136585 |
| DIPYRIDAMOLE INJECTION, USP | 5MG | LIQUID | Resolved | 2020-01-23 | 2020-04-25 | 104082 |
| DIPYRIDAMOLE INJECTION, USP | 5MG | LIQUID | Resolved | 2020-01-20 | 2020-02-13 | 103733 |
| DIPYRIDAMOLE INJECTION, USP | 5MG | LIQUID | Resolved | 2019-07-05 | 2019-10-02 | 88601 |
| DIPYRIDAMOLE INJECTION, USP | 5MG | LIQUID | Resolved | 2018-12-13 | 2019-03-26 | 69542 |
| DIPYRIDAMOLE INJECTION, USP | 5MG | LIQUID | Resolved | 2018-08-25 | 2018-09-06 | 59148 |
| ERTAPENEM FOR INJECTION | 1G | POWDER FOR SOLUTION | Resolved | 2022-02-08 | 2022-09-21 | 154473 |
| FENTANYL CITRATE INJECTION, USP | 50MCG | SOLUTION | Resolved | 2023-10-03 | 2023-11-17 | 205907 |
| FENTANYL CITRATE INJECTION, USP | 50MCG | SOLUTION | Resolved | 2022-10-02 | 2023-01-16 | 170878 |
| FENTANYL CITRATE INJECTION, USP | 50MCG | SOLUTION | Resolved | 2023-08-03 | 2023-08-31 | 201035 |
| FENTANYL CITRATE INJECTION, USP | 50MCG | SOLUTION | Resolved | 2024-07-05 | 2024-10-03 | 232398 |
| FENTANYL CITRATE INJECTION, USP | 50MCG | SOLUTION | Resolved | 2024-08-23 | 2024-09-19 | 235827 |
| FENTANYL CITRATE INJECTION, USP | 50MCG | SOLUTION | Resolved | 2025-03-13 | 2025-04-15 | 252529 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 4.5G 36G | POWDER FOR SOLUTION | Discontinued | 2024-08-13 | 2024-08-20 | 235203 |
| SODIUM BICARBONATE INJECTION, USP | 42MG | SOLUTION | Discontinued | 2024-10-03 | 2024-10-03 | 239180 |
Showing 1 to 2 of 2